Karen A. Foster - 26 Jul 2021 Form 4 Insider Report for BIOLIFE SOLUTIONS INC (BLFS)

Role
Chief Quality Officer
Signature
/s/ Karen A. Foster
Issuer symbol
BLFS
Transactions as of
26 Jul 2021
Net transactions value
-$712,119
Form type
4
Filing time
28 Jul 2021, 20:00:53 UTC
Previous filing
01 Jul 2021
Next filing
25 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BLFS Common Stock Options Exercise $26,786 +16,333 +22% $1.64* 89,110 26 Jul 2021 Direct
transaction BLFS Common Stock Sale $738,905 -16,333 -18% $45.24 72,777 26 Jul 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BLFS Stock Option (Right to Buy) Options Exercise $0 -16,333 -20% $0.000000 65,328 26 Jul 2021 Common Stock 16,333 $1.64 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2020.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.76 to $46.5 per share, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F3 On December 20, 2016, the reporting person was granted an option to purchase 163,323 shares of common stock which vested in two equal installments on March 8, 2018 and March 8, 2019.